Cognition Therapeutics's total assets for Q1 2025 were $23.50M, a decrease of -22.27% from the previous quarter. CGTX total liabilities were $11.23M for the fiscal quarter, a -2.21% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.